PMID: 9177237Jun 10, 1997Paper

Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): mechanisms for the genetic polymorphism of TPMT activity

Proceedings of the National Academy of Sciences of the United States of America
H L TaiW E Evans

Abstract

TPMT is a cytosolic enzyme that catalyzes the S-methylation of aromatic and heterocyclic sulfhydryl compounds, including medications such as mercaptopurine and thioguanine. TPMT activity exhibits autosomal codominant genetic polymorphism, and patients inheriting TPMT deficiency are at high risk of potentially fatal hematopoietic toxicity. The most prevalent mutant alleles associated with TPMT deficiency in humans have been cloned and characterized (TPMT*2 and TPMT*3A), but the mechanisms for loss of catalytic activity have not been elucidated. In the present study, we established that erythrocyte TPMT activity was significantly related to the amount of TPMT protein on Western blots of erythrocytes from patients with TPMT activities of 0.4-23 units/ml pRBC (rs = 0.99; P < 0.001). Similarly, heterologous expression of wild-type (TPMT*1) and mutant (TPMT*2 and TPMT*3A) human cDNAs in yeast and COS-1 cells demonstrated comparable levels of TPMT mRNA but significantly lower TPMT protein with the mutant cDNAs. Rates of protein synthesis were comparable for wild-type and mutant proteins expressed in yeast and with in vitro translation in rabbit reticulocyte lysates. In contrast, pulse-chase experiments revealed significantly shorter d...Continue Reading

References

Mar 1, 1979·Computer Programs in Biomedicine·D Z D'Argenio, A Schumitzky
Nov 6, 1989·European Journal of Biochemistry·Y Rosenberg-HassonC Kahana
Dec 1, 1989·Current Opinion in Cell Biology·T S Olson, J F Dice
Apr 7, 1989·Science·G B Elion
Aug 1, 1989·Clinical Pharmacology and Therapeutics·L LennardR M Weinshilboum
Mar 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·M AmorP C White
Dec 1, 1994·Analytical Biochemistry·A W Henkel, S C Bieger
Apr 7, 1995·The Journal of Biological Chemistry·J A JohnstonA Varshavsky
Feb 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·E Y KrynetskiW E Evans
Feb 13, 1993·Lancet·E S Siris
May 1, 1993·Lancet·T HaakK H Usadel
Feb 1, 1994·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·A Ciechanover, A L Schwartz
Jan 1, 1994·Clinical Pharmacology and Therapeutics·H L McLeodW E Evans
Jul 1, 1993·Molecular Biology of the Cell·A A McCracken, K B Kruse

❮ Previous
Next ❯

Citations

Sep 7, 2004·Transplant International : Official Journal of the European Society for Organ Transplantation·Margarete A FabreSara E Marshall
May 29, 2008·European Journal of Clinical Pharmacology·Srikumar SahasranamanSandip Roy
Mar 17, 2012·European Journal of Clinical Pharmacology·Tiphaine Adam de Beaumais, Evelyne Jacqz-Aigrain
Nov 4, 2005·Investigational New Drugs·Sally Coulthard, Linda Hogarth
Apr 15, 2005·Mutation Research·Thierry DervieuxBruce Neri
May 14, 2005·Pharmacology & Therapeutics·Thomas Efferth, Manfred Volm
Jul 24, 2002·Clinica Chimica Acta; International Journal of Clinical Chemistry·Akihito NishidaTatsuji Iga
Mar 6, 2003·Biochimica Et Biophysica Acta·James W Watters, Howard L McLeod
Mar 14, 2003·Cancer Treatment Reviews·Jeffrey E Rubnitz, Ching-Hon Pui
Jan 20, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L Iyer, M J Ratain
Jan 29, 2009·Nature Clinical Practice. Oncology·Christine M Walko, Howard McLeod
Sep 2, 2004·Nature Reviews. Drug Discovery·Richard Weinshilboum, Liewei Wang
Aug 10, 2011·Nature Reviews. Rheumatology·Lesley Davila, Prabha Ranganathan
Mar 23, 2002·The Pharmacogenomics Journal·S A Coulthard, A G Hall
Dec 21, 2002·Alimentary Pharmacology & Therapeutics·L O ReutherK Schmiegelow
Feb 7, 2003·The New England Journal of Medicine·Richard Weinshilboum
Apr 9, 2004·The New England Journal of Medicine·Ching-Hon PuiJames R Downing
Apr 29, 1998·Human Gene Therapy·A SalvettiP Moullier
Jul 27, 2002·Journal of Pediatric Hematology/oncology·William E Evans
Oct 13, 2005·Pharmacogenetics and Genomics·Oreste E SalavaggioneRichard M Weinshilboum
Mar 16, 2006·Pharmacogenetics and Genomics·Yvette N MartinRichard M Weinshilboum
Aug 19, 2008·Pharmacogenetics and Genomics·Shuta UjiieMasahiro Hiratsuka
Sep 30, 2008·Pharmacogenetics and Genomics·Fang LiRichard M Weinshilboum
Feb 16, 2010·Pharmacogenetics and Genomics·Liewei WangTeri E Klein
Feb 15, 2013·Pharmacogenetics and Genomics·Malin L AppellSally A Coulthard
Nov 30, 2006·Current Opinion in Gastroenterology·Irfan M HisamuddinVincent W Yang
Sep 5, 2006·Annual Review of Genomics and Human Genetics·Richard M Weinshilboum, Liewei Wang
Jan 15, 2003·Annual Review of Medicine·R NagasubramanianM J Ratain
May 20, 1999·Annual Review of Pharmacology and Toxicology·R M WeinshilboumC L Szumlanski
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·H L McLeod, W E Evans

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.